SB463

Requiring Bureau for Public Health to test for mucopolysaccharidosis type 1

Introduced·1/16/26
Intr Text

West Virginia SB463 mandates newborn testing for mucopolysaccharidosis type 1 and other specified diseases.

West Virginia SB463 requires the Bureau for Public Health to test newborns for mucopolysaccharidosis type 1, a metabolic disorder, and other specified diseases. The bill mandates that hospitals or birthing centers, parents or legal guardians, and attending physicians ensure these tests are conducted. A positive result for any specified disease must be reported to the Bureau for Public Health. The Bureau is also tasked with proposing rules for legislative approval, including means for medical, dietary, and related assistance for afflicted children.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Health and Human Resources Committee
Next
Committee decision

Sponsors

0
1
R
Democratic CaucusRepublican Caucus

History

Jan 16

Senate

Filed for introduction

Jan 16

Senate

To Health and Human Resources then Finance

Jan 16

Senate

Introduced in Senate